https://cy2026rarediseases.com/presentations-pdf/advanced-therapy-development-for-erythroid-blood-disorders-carsten-w-lederer/2026-06-23T15:09:29+03:00https://cy2026rarediseases.com/presentations-pdf/amplifying-patient-and-public-involvement-in-small-rare-diseases-ecosystems-spyros-polyviou/2026-06-23T15:09:48+03:00https://cy2026rarediseases.com/presentations-pdf/capacity-building-and-interdisciplinary-training-for-delivering-novel-therapies-andreas-mamilos/2026-06-23T15:09:59+03:00https://cy2026rarediseases.com/presentations-pdf/developing-therapies-for-rare-paediatric-endorcine-disorders-nicolas-nicolaides/2026-06-23T15:10:10+03:00https://cy2026rarediseases.com/presentations-pdf/erdera-research-initiatives-for-therapy-development-in-rare-diseases-daria-julkowska/2026-06-23T15:10:27+03:00https://cy2026rarediseases.com/presentations-pdf/european-networking-for-rare-equity-or-justice-violetta-anastasiadou/2026-06-23T15:10:44+03:00https://cy2026rarediseases.com/presentations-pdf/european-research-on-rare-diseases-carmen-laplaza-santos/2026-06-23T15:11:03+03:00https://cy2026rarediseases.com/presentations-pdf/funding-and-patient-advocacy-organisations-spearheading-the-effort-against-rare-diseases-francois-lamy/2026-06-23T15:11:16+03:00https://cy2026rarediseases.com/presentations-pdf/infrastructure-considerations-for-delivering-therapies-at-scale-frances-example-anne-sophie-lapointe/2026-06-23T15:11:53+03:00https://cy2026rarediseases.com/presentations-pdf/innovative-platform-based-approach-for-sustainable-repurposing-of-medicines-for-rare-diseases-anton-ussi/2026-06-23T15:12:21+03:00https://cy2026rarediseases.com/presentations-pdf/introducing-initiatives-to-bring-more-clinical-trials-to-europe-helene-le-borgne/2026-06-23T15:12:41+03:00https://cy2026rarediseases.com/presentations-pdf/mind-the-access-gap-cost-effectiveness-aspirations-against-scientific-realities-marina-vasiliou/2026-06-23T15:13:31+03:00https://cy2026rarediseases.com/presentations-pdf/national-biobanks-for-population-and-rare-disease-research-giedre-kvedaraviciene/2026-06-23T15:13:46+03:00https://cy2026rarediseases.com/presentations-pdf/network-medicine-and-pharmacology-for-rare-diseasesn-harald-schmidt/2026-06-23T15:14:01+03:00https://cy2026rarediseases.com/presentations-pdf/rare-diseases-research-therapies-and-social-impact-panikos-voskos/2026-06-23T15:14:14+03:00https://cy2026rarediseases.com/presentations-pdf/regulatory-considerations-for-rare-disease-drug-development-and-approval-segundo-mariz/2026-06-23T15:14:28+03:00https://cy2026rarediseases.com/presentations-pdf/the-current-state-of-affairs-for-developing-rational-therapies-for-rare-diseases-holm-graessner/2026-06-23T15:14:43+03:00https://cy2026rarediseases.com/presentations-pdf/the-european-economic-and-social-committees-exploratory-opinion-milena-angelova/2026-06-23T15:14:55+03:00https://cy2026rarediseases.com/presentations-pdf/the-european-platform-on-rare-disease-registration-andri-papadopoulou/2026-06-23T15:15:08+03:00https://cy2026rarediseases.com/presentations-pdf/the-role-of-cing-in-caring-for-patients-with-rare-diseases-leonidas-phylactou/2026-06-23T15:15:18+03:00https://cy2026rarediseases.com/presentations-pdf/witnessing-and-implementing-change-over-the-past-2-decades-stella-kyriakides/2026-06-23T15:15:29+03:00